Is there any vindication for low dose nonselective β-blocker medication in patients with liver cirrhosis?
about
Management of Hepatocellular Carcinoma in Cirrhotic Patients with Portal Hypertension: Relevance of Hagen-Poiseuille's LawNon-selective beta-blockers may reduce risk of hepatocellular carcinoma: a meta-analysis of randomized trials.Does Angiotensin-Converting Enzyme Inhibitor and β-Blocker Use Reduce the Risk of Primary Liver Cancer? A Case-Control Study Using the U.K. Clinical Practice Research Datalink.Propranolol reduces systemic oxidative stress and endotoxemia in cirrhotic patients with esophageal varices.
P2860
Is there any vindication for low dose nonselective β-blocker medication in patients with liver cirrhosis?
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Is there any vindication for l ...... patients with liver cirrhosis?
@ast
Is there any vindication for l ...... patients with liver cirrhosis?
@en
type
label
Is there any vindication for l ...... patients with liver cirrhosis?
@ast
Is there any vindication for l ...... patients with liver cirrhosis?
@en
prefLabel
Is there any vindication for l ...... patients with liver cirrhosis?
@ast
Is there any vindication for l ...... patients with liver cirrhosis?
@en
P2093
P2860
P1476
Is there any vindication for l ...... patients with liver cirrhosis?
@en
P2093
Byung Ik Kim
Chang Uk Chon
Chong Il Sohn
Dong Il Park
Hong Joo Kim
Hyun Sun Won
Jung Ho Park
Tae Wan Kim
Woo Kyu Jeon
Yong Kyun Cho
P2860
P304
P356
10.3350/CMH.2012.18.2.203
P577
2012-06-26T00:00:00Z